Change in LDH assay can affect classification of pleural effusions using Light's criteria

M. Evison, M. Al-Aloul, A. Bentley, N. Chaudhuri, E. Hinchliffe, A. M. Kelly, J. Holme (Manchester, United Kingdom)

Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Session: Clinical problems in mediastinal and pleural malignacies
Session type: Poster Discussion
Number: 3085
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Evison, M. Al-Aloul, A. Bentley, N. Chaudhuri, E. Hinchliffe, A. M. Kelly, J. Holme (Manchester, United Kingdom). Change in LDH assay can affect classification of pleural effusions using Light's criteria. Eur Respir J 2013; 42: Suppl. 57, 3085

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



Role of Dr-70 immunoassay in suspected malignant pleural effusion
Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer
Year: 2013


Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Comparison of the effectiveness of Light criteria and some other proposed criteria in differentiation of pleural fluids as exudates or transudates
Source: Annual Congress 2003 - Pleural effusion
Year: 2003


Biological markers of successful pleurodesis for malignant pleural effusion
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016


A simple score based on ultrasound criteria to distinguish between exudative vs. transudative pleural effusions
Source: International Congress 2014 – Different modalities and techniques for lung imaging
Year: 2014


Expression of YKL-40 and MIP-1a proteins in exudates and transudates: Biomarkers for differential diagnosis of pleural effusions?
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Diagnostic value of pleural fluid adenosine deaminase level in patient with tuberculous pleurisy
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016


Analysis of amylase rich pleural effusions
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Ideal volume sampling in the diagnosis of malignant pleural effusions. Just how much is really enough?
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013

Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016


High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013


Diagnostic values of inflammation biomarkers in pleural effusions (PE)
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015

Discordant exudates and their impact on Light’s criteria accuracy to diagnose exudate effusions. The value of clinical presentation
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Potential role of total antioxidant status ratio in differential diagnosis of pleural effusion
Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases
Year: 2013


Detection of mesothelin in the pleural effusion has a higher diagnostic utility than in serum for diagnostic of malignant mesothelioma
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

Association of biochemical determinants and fibrinous formation in malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Contribution of PIPE Score on prognostic evaluation of idiopathic pleural effusions (IPE)
Source: International Congress 2016 – Pleural diseases
Year: 2016


Molecular assay for tuberculous pleural effusion
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013